|Articles|October 1, 2019
- BioPharm International-10-01-2019
- Volume 32
- Issue 10
BioPharm International, October 2019 Issue (PDF)
Click the title above to open the BioPharm International October 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Driving Improved Access to Biosimilarsover 6 years ago
Technology Redefines Continuous Processing Efficiencyover 6 years ago
Image Repair Must Start with the Root Causeover 6 years ago
Best Practices for Selecting a Top-Quality Cell Lineover 6 years ago
Data Integrity Violations Draw Strong FDA Rebukesover 6 years ago
ALCOA+ and Data Integrityover 6 years ago
Using Software in Process Validationover 6 years ago
Streamlining Operations in Fill/Finishover 6 years ago
Outsourcing Early Development OperationsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
